549 related articles for article (PubMed ID: 23941283)
1. Genetics of amyotrophic lateral sclerosis: an update.
Chen S; Sayana P; Zhang X; Le W
Mol Neurodegener; 2013 Aug; 8():28. PubMed ID: 23941283
[TBL] [Abstract][Full Text] [Related]
2. Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis.
Riancho J; Gonzalo I; Ruiz-Soto M; Berciano J
Neurologia (Engl Ed); 2019; 34(1):27-37. PubMed ID: 26853842
[TBL] [Abstract][Full Text] [Related]
3. Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesis.
Ravits J; Appel S; Baloh RH; Barohn R; Brooks BR; Elman L; Floeter MK; Henderson C; Lomen-Hoerth C; Macklis JD; McCluskey L; Mitsumoto H; Przedborski S; Rothstein J; Trojanowski JQ; van den Berg LH; Ringel S
Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14 Suppl 1(0 1):5-18. PubMed ID: 23678876
[TBL] [Abstract][Full Text] [Related]
4. Advances in genetics research in the pathogenesis of amyotrophic lateral sclerosis.
Wang Y; Yi H; Liao Q; Bi F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 45(12):1483-1489. PubMed ID: 33473007
[TBL] [Abstract][Full Text] [Related]
5. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis.
Sundaramoorthy V; Walker AK; Tan V; Fifita JA; Mccann EP; Williams KL; Blair IP; Guillemin GJ; Farg MA; Atkin JD
Hum Mol Genet; 2015 Jul; 24(13):3830-46. PubMed ID: 25859013
[TBL] [Abstract][Full Text] [Related]
6. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
7. Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.
Maurel C; Dangoumau A; Marouillat S; Brulard C; Chami A; Hergesheimer R; Corcia P; Blasco H; Andres CR; Vourc'h P
Mol Neurobiol; 2018 Aug; 55(8):6480-6499. PubMed ID: 29322304
[TBL] [Abstract][Full Text] [Related]
8. Current Concepts on Genetic Aspects of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
Jankovic M; Novakovic I; Gamil Anwar Dawod P; Gamil Anwar Dawod A; Drinic A; Abdel Motaleb FI; Ducic S; Nikolic D
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575995
[TBL] [Abstract][Full Text] [Related]
9. CSF markers in amyotrophic lateral sclerosis.
Tarasiuk J; Kułakowska A; Drozdowski W; Kornhuber J; Lewczuk P
J Neural Transm (Vienna); 2012 Jul; 119(7):747-57. PubMed ID: 22555610
[TBL] [Abstract][Full Text] [Related]
10. Amyotrophic lateral sclerosis phenotypes significantly differ in terms of magnetic susceptibility properties of the precentral cortex.
Conte G; Contarino VE; Casale S; Morelli C; Sbaraini S; Scola E; Trogu F; Siggillino S; Cinnante CM; Caschera L; Lo Russo FM; Triulzi FM; Silani V
Eur Radiol; 2021 Jul; 31(7):5272-5280. PubMed ID: 33399906
[TBL] [Abstract][Full Text] [Related]
11. A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis.
Conte G; Sbaraini S; Morelli C; Casale S; Caschera L; Contarino VE; Scola E; Cinnante C; Trogu F; Triulzi F; Silani V
Eur Radiol; 2021 Mar; 31(3):1281-1289. PubMed ID: 32886203
[TBL] [Abstract][Full Text] [Related]
12. Current potential pathogenic mechanisms of copper-zinc superoxide dismutase 1 (SOD1) in amyotrophic lateral sclerosis.
Wang XX; Chen WZ; Li C; Xu RS
Rev Neurosci; 2024 Feb; ():. PubMed ID: 38381656
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.
Vucic S; Kiernan MC
Curr Mol Med; 2009 Apr; 9(3):255-72. PubMed ID: 19355908
[TBL] [Abstract][Full Text] [Related]
14. Genetics of amyotrophic lateral sclerosis.
Corcia P; Couratier P; Blasco H; Andres CR; Beltran S; Meininger V; Vourc'h P
Rev Neurol (Paris); 2017 May; 173(5):254-262. PubMed ID: 28449881
[TBL] [Abstract][Full Text] [Related]
15. Molecular motor proteins and amyotrophic lateral sclerosis.
Soo KY; Farg M; Atkin JD
Int J Mol Sci; 2011; 12(12):9057-82. PubMed ID: 22272119
[TBL] [Abstract][Full Text] [Related]
16. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention.
Cozzolino M; Pesaresi MG; Gerbino V; Grosskreutz J; Carrì MT
Antioxid Redox Signal; 2012 Nov; 17(9):1277-330. PubMed ID: 22413952
[TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis.
Jackson CE; Bryan WW
Semin Neurol; 1998; 18(1):27-39. PubMed ID: 9562665
[TBL] [Abstract][Full Text] [Related]
18. Modelling amyotrophic lateral sclerosis: progress and possibilities.
Van Damme P; Robberecht W; Van Den Bosch L
Dis Model Mech; 2017 May; 10(5):537-549. PubMed ID: 28468939
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis.
Yousefian-Jazi A; Seol Y; Kim J; Ryu HL; Lee J; Ryu H
Cells; 2020 Dec; 9(12):. PubMed ID: 33333804
[TBL] [Abstract][Full Text] [Related]
20. IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW.
Gois AM; Mendonça DMF; Freire MAM; Santos JR
Brain Res Bull; 2020 Jun; 159():32-43. PubMed ID: 32247802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
